Skip to main content

Table 2 Utility values for modeled health states [19, 20]

From: Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine

Health State Utility (SD) Disease severity/Assumptions
Active UC: 1st line 0.589 (0.269) Mild-to-moderate active disease (SCAI = 4-10)
Active UC: 1st line increased dosage 0.589 (0.269) Mild-to-moderate active disease (SCAI = 4-10)
Active UC: 2nd line 0.589 (0.269) Mild-to-moderate active disease (SCAI = 4-10)
Active UC: Failure/relapse 0.317 (0.315) Severely active disease (SCAI > 10)
Surgery 0.317 (0.315) Assumption: utility is equal to the utility of patients with relapse
Post surgery 0.845 (0.195) Assumption: utility is equal to the utility of patients in remission
Remission 0.845 (0.195) Patients in remission (SCAI < 4)